BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35973227)

  • 21. The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study.
    Schindler EA; Takita C; Collado-Mesa F; Reis IM; Zhao W; Yang GR; Acosta LG; Hu JJ
    BMC Womens Health; 2024 May; 24(1):312. PubMed ID: 38816709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype.
    Sun X; Nichols HB; Robinson W; Sherman ME; Olshan AF; Troester MA
    Cancer Causes Control; 2015 Dec; 26(12):1803-11. PubMed ID: 26428518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer.
    Ren X; Song Y; Zhang Y; Wu H; Chen L; Pang J; Zhou L; Shen S; Liang Z
    BMC Cancer; 2022 May; 22(1):548. PubMed ID: 35568835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study.
    Phakathi B; Dix-Peek T; Van Den Berg E; Dickens C; Nietz S; Cubasch H; Joffe M; Neugut AI; Jacobson JS; Ruff P; Duarte R
    Breast Cancer Res Treat; 2023 Aug; 200(3):337-346. PubMed ID: 37266756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression.
    Kwan ML; Kroenke CH; Sweeney C; Bernard PS; Weltzien EK; Castillo A; Factor RE; Maxfield KS; Stijleman IJ; Kushi LH; Quesenberry CP; Habel LA; Caan BJ
    BMC Cancer; 2015 Apr; 15():278. PubMed ID: 25884832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor pathway expression in breast cancer by race and subtype.
    Jones GS; Hoadley KA; Olsson LT; Hamilton AM; Bhattacharya A; Kirk EL; Tipaldos HJ; Fleming JM; Love MI; Nichols HB; Olshan AF; Troester MA
    Breast Cancer Res; 2021 Aug; 23(1):80. PubMed ID: 34344422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort.
    Chung GKK; Yeo W; Cheng A; Kwok C; Lei Y; Cheung KL; Lee R; Ho SC
    Breast Cancer Res Treat; 2022 Jun; 193(3):649-658. PubMed ID: 35429323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BIRC5 expression by race, age and clinical factors in breast cancer patients.
    Hamilton AM; Walens A; Van Alsten SC; Olsson LT; Nsonwu-Farley J; Gao X; Kirk EL; Perou CM; Carey LA; Troester MA; Abdou Y
    Breast Cancer Res; 2024 Mar; 26(1):50. PubMed ID: 38515208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined effect of adiposity, fat distribution and age on cardiovascular risk factors and motor disability in a cohort of obese women (aged 18-83).
    Lafortuna CL; Agosti F; Proietti M; Adorni F; Sartorio A
    J Endocrinol Invest; 2006 Nov; 29(10):905-12. PubMed ID: 17185900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of postmenopausal body mass index and waist hip ratio in the oklahoma postmenopausal health disparities study.
    Gavaler JS; Rosenblum E
    J Am Coll Nutr; 2003 Aug; 22(4):269-76. PubMed ID: 12897040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.
    Dawood S; Lei X; Litton JK; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM
    Clin Breast Cancer; 2012 Oct; 12(5):364-72. PubMed ID: 23040004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
    Hoskins KF; Danciu OC; Ko NY; Calip GS
    JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
    Godina C; Belting M; Vallon-Christersson J; Isaksson K; Bosch A; Jernström H
    Sci Rep; 2024 Mar; 14(1):6675. PubMed ID: 38509243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.
    Scholz C; Andergassen U; Hepp P; Schindlbeck C; Friedl TW; Harbeck N; Kiechle M; Sommer H; Hauner H; Friese K; Rack B; Janni W
    Breast Cancer Res Treat; 2015 Jun; 151(3):569-76. PubMed ID: 25962694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity, mammography use and accuracy, and advanced breast cancer risk.
    Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
    J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse.
    Falato C; Tobin NP; Lorent J; Lindström LS; Bergh J; Foukakis T
    Mol Oncol; 2016 Apr; 10(4):517-25. PubMed ID: 26651914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
    Dieci MV; Conte P; Bisagni G; Bartolini S; Frassoldati A; Generali D; Piacentini F; Griguolo G; Tagliafico E; Brasó Maristany F; Chic N; Paré L; Miglietta F; Vicini R; D'Amico R; Balduzzi S; Prat A; Guarneri V
    J Natl Cancer Inst; 2024 Jan; 116(1):69-80. PubMed ID: 37676829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reassessing the causal role of obesity in breast cancer susceptibility: a comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure.
    Hao Y; Xiao J; Liang Y; Wu X; Zhang H; Xiao C; Zhang L; Burgess S; Wang N; Zhao X; Kraft P; Li J; Jiang X
    Int J Epidemiol; 2023 Feb; 52(1):58-70. PubMed ID: 35848946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
    Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
    BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.